According to the latest data from the United States National Library of Medicine, the percentage of clinical trials in India has reduced from 1.5% as of Feb 2017 to 1.2% Feb 2019. This has raised health worries because India has 18% of the world population with 20% global disease burden. India’s clinical trial process is one of the most stringent systems in the world. In this regard, in July 2018 World Health Organization cautioned health minister that with such stringent rules for clinical trial process, India will not progress in clinical research.
According to Public health experts, India needs more clinical research to develop new medicines, vaccines, devices etc. to tackle the huge disease burden. Source- Livemint Do you think it will be helpful if India smoothens the Clinical Trial Process? Yes No
